Total Payments
$3,475
2024 Payments
$674.15
Companies
35
Transactions
200
Medicare Patients
755
Medicare Billing
$105,721
Payment Breakdown by Category
Food & Beverage$3,414 (98.2%)
Education$61.50 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,414 | 199 | 98.2% |
| Education | $61.50 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $497.60 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $489.27 | 20 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $218.84 | 23 | $0 (2022) |
| Lilly USA, LLC | $185.11 | 8 | $0 (2024) |
| GENZYME CORPORATION | $176.84 | 9 | $0 (2022) |
| Amgen Inc. | $127.25 | 6 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $124.67 | 12 | $0 (2021) |
| Genentech USA, Inc. | $116.06 | 6 | $0 (2022) |
| Celgene Corporation | $113.57 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $112.82 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $674.15 | 41 | ABBVIE INC. ($357.01) |
| 2023 | $124.85 | 7 | EMD Serono, Inc. ($52.24) |
| 2022 | $1,859 | 106 | Teva Pharmaceuticals USA, Inc. ($235.10) |
| 2021 | $798.63 | 45 | Teva Pharmaceuticals USA, Inc. ($136.34) |
| 2019 | $19.09 | 1 | Greenwich Biosciences, Inc. ($19.09) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Central Nervous System | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Neuroscience | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 132 | 138 | $40,507 | $16,605 |
| 2022 | 12 | 517 | 773 | $179,163 | $75,821 |
| 2021 | 6 | 106 | 119 | $33,229 | $13,295 |
Total Patients
755
Total Services
1,030
Medicare Billing
$105,721
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 51 | $10,759 | $4,774 | 44.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 31 | $8,856 | $4,041 | 45.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $8,347 | $2,803 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,470 | $2,563 | 39.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,075 | $2,424 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 193 | $38,797 | $18,363 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $24,380 | $10,759 | 44.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 36 | 36 | $22,572 | $10,481 | 46.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 65 | $18,367 | $8,565 | 46.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 50 | $16,450 | $7,647 | 46.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 44 | 83 | $13,031 | $6,534 | 50.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $9,380 | $4,476 | 47.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 22 | 22 | $9,372 | $4,121 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 21 | $2,987 | $1,478 | 49.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 17 | $2,890 | $1,346 | 46.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 27 | 28 | $17,556 | $1,241 | 7.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 69 | $2,760 | $724.20 | 26.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 17 | 69 | $621.00 | $87.24 | 14.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $9,010 | $4,297 | 47.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $7,705 | $3,823 | 49.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 12 | 23 | $3,611 | $1,853 | 51.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 15 | $2,703 | $1,504 | 55.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $2,676 | $1,273 | 47.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 11 | 12 | $7,524 | $543.96 | 7.2% |
About Dr. Patrick Burke, MD
Dr. Patrick Burke, MD is a Neurology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1215384466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Burke, MD has received a total of $3,475 in payments from pharmaceutical and medical device companies, with $674.15 received in 2024. These payments were reported across 200 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,414).
As a Medicare-enrolled provider, Burke has provided services to 755 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $105,721. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Syracuse, NY
- Active Since 05/18/2016
- Last Updated 11/21/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1215384466
Products in Payments
- NURTEC ODT (Drug) $343.51
- QULIPTA (Drug) $285.60
- ZEPOSIA (Drug) $226.39
- AUSTEDO (Drug) $209.13
- AUBAGIO (Drug) $176.84
- UBRELVY (Drug) $172.04
- EMGALITY (Drug) $164.39
- AJOVY (Biological) $156.07
- Aimovig (Biological) $127.25
- Briviact (Drug) $103.20
- BOTOX (Biological) $102.18
- RYTARY (Drug) $97.99
- Fycompa (Drug) $93.29
- OCREVUS (Biological) $76.92
- VYEPTI (Biological) $74.15
- QELBREE (Drug) $63.84
- Austedo XR (Drug) $62.57
- TYSABRI (Biological) $59.36
- MAVENCLAD (Drug) $52.24
- VNS Therapy SenTiva Model 1000 Generator (Device) $48.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Syracuse
Antonio Culebras, M.d, M.D
Neurology — Payments: $53,485
Neurology $53,485
Dr. Corey Mcgraw, M.d, M.D
Neurology — Payments: $8,081
Neurology $8,081
Victoria Minyo, D.o, D.O
Neurology — Payments: $7,856
Neurology $7,856
Sami Abdul-Malak, Md, MD
Neurology — Payments: $3,671
Neurology $3,671
Dr. Susama Verma, Md, MD
Neurology — Payments: $3,390
Neurology $3,390
Dr. Hassan Elnour, M.d, M.D
Neurology — Payments: $2,758
Neurology $2,758